The Innovative Medicines Fund provides a consistent and transparent managed access process for companies offering promising non-cancer medicines at a responsible price.

The Innovative Medicines Fund is a key part of the health systems’ readiness for the continued adoption of advanced therapy medicinal products, building on recent positive NICE appraisals for, and NHS adoption of, cutting-edge non-cancer treatments.